Skip to main content
. 2019 Oct;148:104442. doi: 10.1016/j.phrs.2019.104442

Fig. 3.

Fig. 3

Molecular stratification of patients with IBD. Patients following conventional therapy might be stratified based on predicted disease severity and outcome to determine if aggressive or milder therapeutics should initially be given. Subsequently, the patients may be further stratified based on their likelihood of responding to specific biologics.